Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 19 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ABVC BioPharma Inc | ABVC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.05 | 05:53:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.05 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 5 | 19 | - | 0.6739 - 9.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 06:42:49 | 1 | $ 1.04 | USD |
ABVC BioPharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.09M | 10.56M | - | 152k | -10.52M | -1.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ABVC BioPharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABVC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.15 | 1.19 | 0.94 | 1.04 | 555,191 | -0.10 | -8.70% |
| 1 Month | 1.07 | 1.45 | 0.94 | 1.25 | 1,975,344 | -0.02 | -1.87% |
| 3 Months | 1.26 | 1.54 | 0.94 | 1.26 | 762,082 | -0.21 | -16.67% |
| 6 Months | 0.93 | 3.35 | 0.82 | 1.53 | 2,475,103 | 0.12 | 12.90% |
| 1 Year | 6.70 | 9.60 | 0.6739 | 1.99 | 1,462,064 | -5.65 | -84.33% |
| 3 Years | 33.20 | 116.883 | 0.6739 | 18.36 | 1,000,596 | -32.15 | -96.84% |
| 5 Years | 33.20 | 116.883 | 0.6739 | 18.36 | 1,000,596 | -32.15 | -96.84% |
ABVC BioPharma Description
| ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes that represent enormous commercial potential. |
